Nipah Virus Infection Testing Market
Nipah Virus Infection Testing Market Size, Share & Trends Analysis Report By Test (RT PCR Based Kits, and ELISA Kits), By Sample (Blood Serum or Plasma, Saliva and Throat Swabs, Urine, and Others), By End-User (Hospitals, Research Institutions, Diagnostic Centers, and Others), Forecast Period (2023-2030) Update Available - Forecast 2024-2030
Nipah virus infection testing market is anticipated to grow at a CAGR of 4.8% during the forecast period (2023-2030). The market’s growth is attributed to the growing incidence of Nipah virus infection across the globe. NiV can be passed from infected animals (such as pigs or bats) or their bodily fluids to individuals through contact. It involves fluids including blood, urine, and saliva. According to the National Institute of Health, in March 2023, Encephalitis and NiV infection are connected (inflammation of the brain). After exposure and a period lasting from 5 to 14 days, the illness starts with a fever and headache that persist for 3–14 days. Lethargy, disorientation, and confusion may then follow. Within 24–48 hours, these signs and symptoms may progress to a coma. Early in their infections, some individuals may experience respiratory issues, and 50% of those who exhibited severe neurological symptoms additionally had pulmonary symptoms. Transmission of NiV may occur through contact with infected animals such as pigs or bats, or their body fluids (such as saliva, urine, or blood). During the first recorded NiV outbreak, people contracted the virus through close contact with sick pigs. The NiV strain found during that outbreak seemed to have initially spread among bats, then to pigs, and finally to pig populations.
Segmental Outlook
The global Nipah virus infection testing market is segmented on the test type, sample, and end-user. Based on the test type, the market is sub-segmented into RT PCR-based kits, and ELISA Kits. Based on the sample, the market is sub-segmented into blood serum or plasma, saliva and throat swabs, urine, and others. Furthermore, based on the market is sub-segmented into hospitals, research institutions, diagnostic centers, and others.
The ELISA Kits Sub-Segment is Anticipated to Contribute Significantly to the Global Nipah Virus Infection Testing Market
Among the test types, the ELISA Kits sub-segment is expected to hold a considerable share of the global Nipah virus infection testing market. The segmental growth is attributed to the increasing ELISA testing adoption. There is potential for an expansion in the use of the tests in clinical and public health settings as ELISA has proven to be a viable technique for Nipah virus detection. Economical and effective diagnostic technologies such as ELISA can be utilized in large-scale epidemiological investigations. According to the National Institute of Health (gov.), in September 2022, ELISA is an effective, safe, and cost-efficient diagnostic tool that can be used to detect Nipah virus in large-scale epidemiological investigations. IgM and IgG ELISA tests can also help inform public health interventions. Furthermore, in comparison to a reference test from the Centers for Disease Control and Prevention (CDC), US, the developed anti-NiV IgM and IgG ELISAs demonstrated a specificity of 99.28% and a sensitivity of 100%. Anti-Nipah IgM and IgG ELISA assays showed 100% negative predictive value and 90% and 93.94% positive predictive value, respectively, with test accuracy of 99.33%.
Regional Outlook
The global Nipah virus infection testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).
Global Nipah Virus Infection Testing Market Growth by Region 2023-2030
The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Nipah Virus Infection Testing Market
Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the increasing demand for testing. The reported cases in Kerala emphasize the significance it is to having accurate and widely available diagnostic procedures for the Nipah virus. Testing for diagnosis, contact tracing, and epidemic management are all required after cases are confirmed.
According to the World Health Organization (WHO), in October 2023, since 12 September, 387 samples have been tested, resulting in six positive cases of Nipah virus infection and 381 negative samples. Furthermore, six laboratory-confirmed cases of Nipah virus infection, including two fatalities, were reported between September 12 and September 15, 2023, according to the Kerala State Government. Males between the ages of 9 and 45 were involved in every confirmed instance, which was recorded in Kerala's Kozhikode district.
Market Players Outlook
The major companies serving the Nipah virus infection testing market include Creative Biogene, Jiangsu Bioperfectus Technologies Co., Ltd., Molbio Diagnostics Pvt. Ltd., and YouSeq Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2023, Kerala received monoclonal antibodies from the Indian Council of Medical Research (ICMR) and to combat the ongoing Nipah virus outbreak, a mobile laboratory has been set up at the center of the state.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Nipah virus infection testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
1.1.1. Overview
1.1.2. Financial Analysis
1.1.3. SWOT Analysis
1.1.4. Recent Developments
1.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Nipah Virus Infection Testing Market by Test Type
4.1.1. RT PCR based kits
4.1.2. ELISA Kits
4.2. Global Nipah Virus Infection Testing Market by Sample Type
4.2.1. Blood Serum or Plasma
4.2.2. Saliva and Throat Swabs
4.2.3. Urine
4.2.4. Others (Cerebrospinal Fluid (CSF), Respiratory Secretions, and Environmental Samples)
4.3. Global Nipah Virus Infection Testing Market by End-User
4.3.1. Hospitals
4.3.2. Research Institutions
4.3.3. Diagnostic Centers
4.3.4. Others (Non-Governmental Organizations (NGOs), Emergency Response Teams, Public Health Authorities)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Creative Biogene.
6.2. Creative Diagnostics
6.3. Indian Council of Medical Research-National Institute of Virus
6.4. Jiangsu Bioperfectus Technologies Co., Ltd
6.5. Liferiver Bio-Tech Corp.
6.6. Molbio Diagnostics Pvt. Ltd.
6.7. MyBioSource
6.8. Pirbright researchers
6.9. YouSeq Ltd
1. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
2. GLOBAL RT PCR BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL ELISA BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
5. GLOBAL NIPAH VIRUS INFECTION TESTING BY BLOOD SERUM OR PLASMA SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
6. GLOBAL NIPAH VIRUS INFECTION TESTING BY SALIVA AND THROAT SWABS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL NIPAH VIRUS INFECTION TESTING BY URINE SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
8. GLOBAL NIPAH VIRUS INFECTION TESTING BY OTHERS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
10. GLOBAL NIPAH VIRUS INFECTION TESTING FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
11. GLOBAL NIPAH VIRUS INFECTION TESTING FOR RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
12. GLOBAL NIPAH VIRUS INFECTION TESTING FOR DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. GLOBAL NIPAH VIRUS INFECTION TESTING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
14. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
15. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
16. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
17. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
18. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
19. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
20. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
21. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
22. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
23. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
24. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
25. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
26. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
27. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
28. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
29. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
1. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022 VS 2030 (%)
2. GLOBAL RT PCR BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
3. GLOBAL ELISA BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
4. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022 VS 2030 (%)
5. GLOBAL NIPAH VIRUS INFECTION TESTING BY BLOOD SERUM OR PLASMA SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
6. GLOBAL NIPAH VIRUS INFECTION TESTING BY SALIVA AND THROAT SWABS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
7. GLOBAL NIPAH VIRUS INFECTION TESTING BY URINE SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
8. GLOBAL NIPAH VIRUS INFECTION TESTING BY OTHERS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
9. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
10. GLOBAL NIPAH VIRUS INFECTION TESTING FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
11. GLOBAL NIPAH VIRUS INFECTION TESTING FOR RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
12. GLOBAL NIPAH VIRUS INFECTION TESTING FOR DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
13. GLOBAL NIPAH VIRUS INFECTION TESTING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
14. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
15. US NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
16. CANADA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
17. UK NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
18. FRANCE NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
19. GERMANY NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
20. ITALY NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
21. SPAIN NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
22. REST OF EUROPE NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
23. INDIA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
24. CHINA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
25. JAPAN NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
26. SOUTH KOREA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
27. REST OF ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
28. LATIN AMERICA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
29. MIDDLE EAST AND AFRICA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
